+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Antigen presentation and T cell stimulation by dendritic cells

Antigen presentation and T cell stimulation by dendritic cells

Annual Review of Immunology 20: 621-667

Dendritic cells take up antigens in peripheral tissues, process them into proteolytic peptides, and load these peptides onto major histocompatibility complex (MHC) class I and II molecules. Dendritic cells then migrate to secondary lymphoid organs and become competent to present antigens to T lymphocytes, thus initiating antigen-specific immune responses, or immunological tolerance. Antigen presentation in dendritic cells is finely regulated: antigen uptake, intracellular transport and degradation, and the traffic of MHC molecules are different in dendritic cells as compared to other antigen-presenting cells. These specializations account for dendritic cells' unique role in the initiation of immune responses and the induction of tolerance. Reprinted by permission of the publisher.

Accession: 009770497

Download citation: RISBibTeXText

PMID: 11861614

DOI: 10.1146/annurev.immunol.20.100301.064828

Download PDF Full Text: Antigen presentation and T cell stimulation by dendritic cells

Related references

Granuloma consisting cells masquerading mature dendritic cells induce antigen presentation and T cell stimulation in Crohns disease. Gastroenterology 120(5 Supplement 1): A 523, April, 2001

Effects of lipofectin-antigen complexes on major histocompatibility complex class I-restricted antigen presentation pathway in murine dendritic cells and on dendritic cell maturation. Biochimica et Biophysica Acta 1527(3): 97-101, 15 August, 2001

TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface. Journal of Immunology 190(3): 948-960, 2013

Enhancement of dendritic cell vaccine by improving in vivo antigen presentation through lentiviral vector modified murine bone marrow cells and GM-CSF stimulation. Proceedings of the American Association for Cancer Research Annual Meeting 44: 355-356, July, 2003

Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells. European Journal Of Immunology. 28(6): -1933, E, 1998

Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses. Clinical and Experimental Immunology 151(2): 284-296, 2007

Acquisition and presentation of follicular dendritic cell-bound antigen by lymph node-resident dendritic cells. Journal of Experimental Medicine 208(1): 135-148, 2011

Lentiviral Mediated Transduction of Dendritic Cell Progenitors Does Not Alter the Maturation and Antigen Presentation Function of Dendritic Cells. FASEB Journal 18(4-5): Abst 85 16, 2004

Antigen presentation by dendritic cells provides optimal stimulation for the production of interleukin (IL) 2, IL 4 and interferon-gamma by allogeneic T cells. European Journal of Immunology 21(11): 2803-2809, 1991

Dendritic cell aggresome-like-induced structure formation and delayed antigen presentation coincide in influenza virus-infected dendritic cells. Journal of Immunology 175(2): 891-898, 2005

ICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD4+ T cells. Blood 108(2): 609-617, 2006

Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances dendritic cell cross-presentation. Vaccine 33(13): 1549-1555, 2016

Glycan modification of the tumor antigen gp100 targets DC-SIGN to enhance dendritic cell induced antigen presentation to T cells. International Journal of Cancer 122(4): 839-846, 2007